A Randomized, Blinded, Positive Vaccine-controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of DTcP in Infants and Children at 2 and 3 Months of Age
Latest Information Update: 20 Mar 2025
At a glance
- Drugs Diphtheria tetanus and pertussis vaccine (Primary) ; DTaP vaccine (Primary) ; Hib-DTaP-poliovirus vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Sponsors Tianjin CanSino Biotechnology
Most Recent Events
- 17 Mar 2025 Planned End Date changed from 1 Aug 2024 to 1 Apr 2025.
- 17 Mar 2025 Planned primary completion date changed from 1 Aug 2024 to 1 Apr 2025.
- 24 Mar 2024 Planned primary completion date changed from 1 Feb 2024 to 1 Aug 2024.